Put Options

18 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $9.42 Million - $29.9 Million
428,300 Added 70.25%
1,038,000 $69.5 Million
Q1 2024

May 15, 2024

BUY
$25.72 - $29.94 $15.3 Million - $17.8 Million
595,600 Added 4224.11%
609,700 $16.5 Million
Q4 2023

Feb 14, 2024

SELL
$23.42 - $31.74 $9.65 Million - $13.1 Million
-412,000 Reduced 96.69%
14,100 $436,000
Q3 2023

Nov 14, 2023

BUY
$19.86 - $26.93 $1.88 Million - $2.55 Million
94,600 Added 28.54%
426,100 $10.8 Million
Q2 2023

Aug 14, 2023

BUY
$16.44 - $21.1 $3.67 Million - $4.72 Million
223,500 Added 206.94%
331,500 $6.99 Million
Q1 2023

May 15, 2023

BUY
$16.26 - $21.73 $1.76 Million - $2.35 Million
108,000 New
108,000 $1.84 Million
Q1 2022

May 13, 2022

BUY
$20.42 - $28.13 $612,600 - $843,900
30,000 New
30,000 $705,000
Q4 2021

Feb 11, 2022

SELL
$25.89 - $33.45 $2.33 Million - $3.01 Million
-90,000 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$22.46 - $29.47 $673,800 - $884,100
30,000 Added 50.0%
90,000 $2.48 Million
Q2 2021

Aug 16, 2021

BUY
$24.17 - $36.01 $725,100 - $1.08 Million
30,000 Added 100.0%
60,000 $1.71 Million
Q3 2020

Nov 16, 2020

BUY
$26.0 - $34.5 $780,000 - $1.04 Million
30,000 New
30,000 $965,000
Q2 2020

Aug 14, 2020

SELL
$14.11 - $29.42 $203,184 - $423,648
-14,400 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$13.63 - $33.98 $452,516 - $1.13 Million
-33,200 Reduced 69.75%
14,400 $231,000
Q4 2019

Feb 13, 2020

SELL
$16.12 - $24.98 $441,688 - $684,452
-27,400 Reduced 36.53%
47,600 $1.14 Million
Q3 2019

Nov 14, 2019

BUY
$15.49 - $25.78 $697,050 - $1.16 Million
45,000 Added 150.0%
75,000 $1.32 Million
Q1 2019

May 14, 2019

SELL
$13.91 - $31.15 $2.45 Million - $5.48 Million
-176,000 Reduced 85.44%
30,000 $872,000
Q4 2018

Jan 30, 2019

BUY
$11.6 - $18.7 $39,440 - $63,580
3,400 Added 1.68%
206,000 $2.7 Million
Q3 2018

Nov 14, 2018

BUY
$18.95 - $28.08 $3.84 Million - $5.69 Million
202,600 New
202,600 $4.1 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.89B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.